Johan Cardoen

Funding Wrap of the Week | European Startup Funding Roundup | May 19 – May 24 Here are the top 10 funding round of this week for these startups, including imec, Bicycle Therapeutics, DeepL, Circtec, Colendi, OneStock, Grey Wolf Therapeutics, Enifer, Zen Educate, Resilience Read more - https://lnkd.in/g2f2K9tj #weeklyroundup #fundraising #vcfunding #eustartup #weeklyfunding #weeklynews #startupfunding #fundingalert #europeanbusiness #investment #startup

25

Manufacturing costs of medicinal products, especially new and highly innovative therapies, is currently one of the most discussed topics in the field. SwiftPharma, a Belgian biotech startup using plants to produce life-saving proteins at low costs, collaborates with Medace to improve the quality and scalability of their production. SwiftPharma makes, among other things, a virus inhibitor for preventing HIV infection and a biosimilar for lowering the costs of oncology treatments. Their technology is market disruptive and represents a paradigm shift in sustainable bioproduction. Read this article to discover how SwiftPharma creates impact and rewrites the possibilities in healthcare with their plant-based solutions 👇🏼 #cleanroom #plantbased #biotech #innovation #healthcare 

15

  🚀 BioPark Charleroi Drives Growth in the European Biotechnology Sector 🧬   Last July, Brussels South Charleroi BioPark took a significant step toward establishing itself as a global player in biomanufacturing. This ambitious project aims to transform its campus, tripling its size and workforce to reach 10,000 jobs in the coming years. Backed by the UMONS and key partners, the plan focuses on strengthening the local life sciences ecosystem through cutting-edge infrastructure and innovation initiatives, including the EU Biotech Campus. These efforts will foster a vibrant environment for startups and established companies alike, promoting research and development in biotechnology, pharmaceuticals, and biomedical research.   For ACCIÓ Brussels , this expansion exemplifies collaboration and development in the biotech sector. Catalonia leads Spain's biotechnology landscape, hosting nearly 25% of all companies in the field. ACCIÓ supports Catalan firms in building networks, attracting investments, and enhancing innovation, with the aim of replicating successful initiatives like BioPark. By fostering connections and partnerships, this development opens doors for synergies and opportunities between Wallonia and Catalonia, ultimately enhancing the competitiveness of both regions in the global biotechnology market. 🌍🔬   #InvestCatalonia #Biotech #Startups #Biopark

14

1 Comment

ᴄᴏɴᴄʟᴜsɪᴏɴs ᴏғ ᴛʜᴇ ᴀɴᴛᴡᴇʀᴘ ᴅᴇᴄʟᴀʀᴀᴛɪᴏɴ Following the adoption of the Council of the European Union Conclusions and the New Strategic Agenda 2024 – 2029, the call for competitiveness has been set high on the European🌍 agenda. We like to inform ℹ you that the conclusions of the Antwerp Dialogue on Biotech are now available. Have a look👀 at the conclusions on the @Antwerp Declaration website: 👉🏼 https://hubs.ly/Q02FNJDR0 This dialogue brought together different viewpoints and emphasised the need for a holistic, ecosystem approach to maximise potential of biotechnology and offered recommendations on: 💶 Mobilising capital and investments 📈 EU measures to stimulate market demand 👷‍♀️ Upskilling and workforce development 💡 Regulatory coherence and predictability 🔎 Scaling up and measuring success #proudtobestepg #IndustrialDeal #AntwerpDeclaration #greendeal #industry #europa #cefic

8

𝘽𝙧𝙚𝙖𝙠𝙞𝙣𝙜 𝙉𝙚𝙬𝙨:Bioprex Medical 𝘀𝗲𝗰𝘂𝗿𝗲𝘀 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗳𝗼𝗿 𝗴𝗿𝗼𝘂𝗻𝗱𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗮𝗻𝘁𝗶𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮𝗹 𝗰𝗼𝗮𝘁𝗶𝗻𝗴 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆!🦠 Bioprex Medical, a Groningen-based biotech startup, has successfully closed a new financing round to advance its patented antibacterial coating technology. Over the coming year, Bioprex will focus on preclinical evaluations and expanding collaborations with medical device and implant manufacturers. 𝗞𝗲𝘆 𝗣𝗼𝗶𝗻𝘁𝘀: 𝗙𝘂𝗻𝗱𝗶𝗻𝗴: Led by Pharma Connect Capital and NV NOM. 𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝘃𝗲:Further develop an antibacterial coating to prevent infections caused by medical devices and implants. 𝗙𝗼𝘂𝗻𝗱𝗲𝗱:2022 as a spin-off from the Zernike Institute for Advanced Materials at the University of Groningen. Bioprex's coating, using quaternary ammonium compounds, kills bacteria before they can adhere to surfaces, addressing a major healthcare issue. With over 4 million annual infections in Europe, this technology could greatly reduce infection rates and healthcare costs, especially as antibiotic resistance rises. Bioprex is now focusing on preclinical evaluations, starting with orthopedic implants like pins and screws, and plans to expand to catheters and other devices. 𝗡𝗲𝘅𝘁 𝘀𝘁𝗲𝗽𝘀: Bioprex will focus on preclinical evaluations, starting with orthopedic implants like pins and screws, with plans to expand to catheters and other devices. #dutchinnovation #biotech #startup #healthcare #innovation https://lnkd.in/dEuR8kDt

35

5 Comments

An important step in Samabriva's development, providing our international partners with industrial capacity

22

3 Comments

Come and find us today at #LabAutomationDay @ Technopolis Mechelen 🔬 We gladly reveal how Toolsquare helps you to improve the productivity (and safety) of your lab!

18

⚡The world of proteomics is moving at lightning speed⚡ ❓“We will soon be facing a huge pile of proteomic data. The question is: what are we going to learn from it?"👉 https://lnkd.in/emefb_sw 🎙️In a interview with imec, Kris Gevaert (VIB-UGent Center for Medical Biotechnology) and Simon Devos (VIB Proteomics Core) discuss the progress and challenges in Proteomics researchers face as they strive to understand proteins at a deeper level. #VIBTechnologies

98

Our 💯 edition of ClimateHack and it's packed with news and funding Take a look: 🔦 Californian biotech Prolific Machines, Inc. raised $55 million Series B1 funding for its photomolecular platform, to develop novel proteins for the food and medicine industries from light. 🍄 Belgian startup Novobiom raised €2 million seed funding for its fungi-based waste treatment solution. 🍫 Israeli startup Kokomodo emerged from stealth with $750,000 in funding from The The Kitchen Hub and the Israeli Innovation Authority to produce cell-based cocoa and chocolate products. 🏭 Israel’s Brevel opened its first commercial-scale microalgae protein facility, a 27,000 sq ft plant capable of producing hundreds of tons of protein for use in dairy alternatives. 🏗 Sublime Systems received a grant of $87 million from the US Department of Energy to produce zero-carbon cement 🏢 German startup ecoLocked raised €4 million for its biocarbon-based concrete admix materials 🌡 Swedish startup Aira raised €200 million in debt financing from BNP Paribas to sell heat pumps to consumers in Germany 📊 Insurance provider Understory raised $15 million Series A funding, in a round co-led by True Ventures and Prelude Ventures ☀️ Samara, based in Spain, secured €9 million Series A funding to accelerate the country’s transition to green energy. 🔎 French startup Sopht raised €3.3 million, in a funding round led by Ring Capital and Climate Club 🔋 ENTROVIEW, based in France, secured $1.6 million for its patented entropy method analysis 🏡 Netherlands-based Prêts secured €1 million to “revolutionise financing for home energy upgrades”. 🔋 US startup SiTration, Inc. secured $11.8 million seed funding to reduce the energy needed for materials extraction ♻️ Nova Carbon raised €1.4 million to drive innovation in recycled carbon fibre. 🪶 UK-based Aeropowder secured £150,000 from the British Design Fund 🖥 Neural Concept raised $27 million to use AI and machine learning to make the EV design process faster and more efficient. 🔌 French startup Gireve secured €20 million from Partech’s Impact Fund 🚲 Whizz raised $12 million to offer gig workers access to safe, high-quality e-bikes on a subscription basis. 🚚 Qargo secured £11 million in a Series A funding round led by Balderton Capital. 🔌 UK-based Fuuse secured £8.7 million to expand its EV charge point management platform across the UK and Ireland. 🚛 Paris-based Decade Energy raised €3.6 million seed funding to create a software platform that supports truck operators’ transitions to electric fleets 🇦🇺 Pollination is launching a new $150 million fund, supported by the Queensland government, for climate and nature tech startups 🇧🇷 Brazilian accelerator Darwin Startups announced a $20 million fund to support pre-seed and seed-stage startups working across sectors including health, agriculture, education, and logistics. Get the full recap: https://lnkd.in/ewGuxbEU

20

2 Comments

Is 3D bioprinting of organs futuristic or closer than we think? Find out how Belgium is leading the way to make this technology a clinical reality👇 https://lnkd.in/eBfaAHAw #bioprinting #futureofhealthcare #healthcareinnovation #belgium

3

We are excited to announce the opening of our new biomanufacturing facility in Liège, Belgium, with Phase 1 set to be operational in Q1 2025. The facility is a major milestone for Samabriva, enabling industrial scale production of high value natural molecules for the manufacture of pharmaceuticals. The investment emphasises our strong commitment to delivering plant-based bioproduction at large scale. By providing customers with full control over the biomanufacturing process, we will deliver a cost effective and sustainable alternative to open field production. Read the full press release here: https://lnkd.in/gbmjuqdn Marina Guillet Bertrand Duquesne Pascal Lizin Florian Cardon #biomanufacturing #bioprocessing #bioproduction #Lifesciences #supplychain #biomolecules #pharmaceuticalindustry

106

4 Comments

Aiosyn is an innovative startup dedicated to advancing 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆, particularly in cancer and kidney diseases, through the application of 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 (AI). Founded as a spin-off from Radboud University Medical Center, Aiosyn develops software solutions that integrate deep learning algorithms into the workflows of pathology labs and biopharma companies, enhancing diagnostic accuracy and efficiency. The company leverages AI to provide data-driven insights, allowing pathologists to make better clinical decisions. By optimizing workflows and offering new perspectives on treatment effectiveness, Aiosyn aims to improve patient outcomes and streamline the diagnostic process in healthcare settings. Explore more: Aiosyn Patrick de Boer David Tellez Wouter Bulten Péter Bándi 𝗕𝗲 𝘁𝗵𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘄𝗼𝗿𝗹𝗱'𝘀 𝗹𝗮𝗿𝗴𝗲𝘀𝘁 𝗔𝗜 𝘀𝘂𝗺𝗺𝗶𝘁: https://bit.ly/3ZrTOET

10

2 Comments

🔹 New Application Note from Cellular Highways and VIB!🔹 We are thrilled to announce our collaborative Application Note with Jochen Lamote (Head of VIB Flow Core Leuven, VIB Technologies) and Ada Nowosad (Lab of Molecular Biology, VIB-KU Leuven Center for Cancer Biology). Discover a workflow for selection and culture of various cells from the tumour microenvironment using Highway1 cell sorter. The Highway1 cell sorter came out on top in terms of viability and growth post-sort, making it the ideal sorter for sensitive cells! Click the link below to read the full application note ⬇ https://lnkd.in/g-yE9n4B #cellisolation #cellsorting #flowcytometry #Highway1

42

6 Comments

Synaffix BV today announces it has licensed its #ADC technology to BigHat Biosciences.   BigHat will combine Synaffix technology with its world-class machine learning #antibody design platform for the development of a new ADC pipeline program.     Under the terms of the agreement, BigHat will receive target-specific access to Synaffix’s late-clinical stage, site-specific ADC technology platform, which enables the transformation of antibodies into proprietary, best-in-class ADC products. BigHat will also gain access to Lonza’s end-to-end ADC offering. For more information on this exciting new collaboration, please read the full press release linked in the comments below. #ADCs #drugdevelopment #innovation #artificialintelligence #machinelearning

108

4 Comments

Modulation of protein-protein interactions (#PPIs) with molecular glues is an emerging strategy in #drugdiscovery, offering potential solutions for targeting 'hard to drug' protein classes. Join us on June 18th for a Cytiva webinar where our scientist, Pim de Vink, will share his experience and discuss common trends with fellow drug discovery scientists. In his presentation Pim will outline a series of #biophysical #assay setups specifically developed for the screening and validation of new #molecularglues using a #fragment-based approach. Register here: https://cytiva.link/4f3de

27